148 related articles for article (PubMed ID: 34403851)
1. Preferential interaction of platelets with prostate cancer cells with stem cell markers.
Rudzinski JK; Govindasamy NP; Asgari A; Saito MS; Lewis JD; Jurasz P
Thromb Res; 2021 Oct; 206():42-51. PubMed ID: 34403851
[TBL] [Abstract][Full Text] [Related]
2. The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion.
Rudzinski JK; Govindasamy NP; Lewis JD; Jurasz P
J Thromb Haemost; 2020 Nov; 18(11):2976-2986. PubMed ID: 32692888
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche.
Faber A; Hoermann K; Stern-Straeter J; Schultz DJ; Goessler UR
Oncol Rep; 2013 Feb; 29(2):579-84. PubMed ID: 23232503
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
[TBL] [Abstract][Full Text] [Related]
6. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4.
Walsh TG; Harper MT; Poole AW
Cell Signal; 2015 Jan; 27(1):37-46. PubMed ID: 25283599
[TBL] [Abstract][Full Text] [Related]
7. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
8. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
[TBL] [Abstract][Full Text] [Related]
9. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
11. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
12. SDF-1α/CXCR4 Signaling in Lipid Rafts Induces Platelet Aggregation via PI3 Kinase-Dependent Akt Phosphorylation.
Ohtsuka H; Iguchi T; Hayashi M; Kaneda M; Iida K; Shimonaka M; Hara T; Arai M; Koike Y; Yamamoto N; Kasahara K
PLoS One; 2017; 12(1):e0169609. PubMed ID: 28072855
[TBL] [Abstract][Full Text] [Related]
13. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
14. Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.
Liu XQ; Fourel L; Dalonneau F; Sadir R; Leal S; Lortat-Jacob H; Weidenhaupt M; Albiges-Rizo C; Picart C
Biomaterials; 2017 May; 127():61-74. PubMed ID: 28279922
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture.
Kiss DL; Windus LC; Avery VM
Cytokine; 2013 Oct; 64(1):122-30. PubMed ID: 23921147
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
[TBL] [Abstract][Full Text] [Related]
17. CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K.
Hira VV; Ploegmakers KJ; Grevers F; Verbovšek U; Silvestre-Roig C; Aronica E; Tigchelaar W; Turnšek TL; Molenaar RJ; Van Noorden CJ
J Histochem Cytochem; 2015 Jul; 63(7):481-93. PubMed ID: 25809793
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
19. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
[TBL] [Abstract][Full Text] [Related]
20. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
